Sort
21,453 grants matching “tuberculosis”
Coupled Macroparasite-Microparasite Interactions: Ecological and Evolutionary Consequences of Coinfection
$596,944Vanessa Ezenwa · University Of Georgia · R01 · FY2018 · GM
A Cambodian Clinical Research Network for HIV & TB
$596,916Sok Thim · Cambodian Health Committee · U01 · FY2009 · AI
UM-IHV AITRP in Nigeria
$596,825William Albert Blattner · University Of Maryland Baltimore · D43 · FY2010 · TW
UM-IHV AITRP in Nigeria
$596,524William Albert Blattner · University Of Maryland Baltimore · D43 · FY2011 · TW
Vaccine and Treatment Evaluation Unit at Saint Louis University
$596,290Daniel F. Hoft · Saint Louis University · UM1 · FY2021 · AI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS
$596,258Jerrold J. Ellner · Boston Medical Center · U01 · FY2011 · AI
NPHCO Core
$596,258Javier Crespo · Univ Of Massachusetts Med Sch Worcester · UG4 · FY2022 · LM
The effect of HIV on SARS-CoV-2 transmission and emergence of variants of concern
$596,211Sanghyuk Sam Shin · University Of California-Irvine · R01 · FY2022 · AI
The role of FENDRR in host defense against Mycobacterium tuberculosis infection
$596,156Yong Cheng · Oklahoma State University Stillwater · R01 · FY2024 · AI
The role of FENDRR in host defense against Mycobacterium tuberculosis infection
$596,156Yong Cheng · Oklahoma State University Stillwater · R01 · FY2023 · AI
Analysis of a novel peptidoglycan assembly pathway in mycobacteria
$595,979Martin S. Pavelka · University Of Rochester · R01 · FY2019 · AI
Regulation of T cell homeostasis and memory
$595,834Linda Mac Pherson Bradley · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · AI
Fostering resilience to psychosocial and HIV risk in Indian MSM
$595,763Conall Michael O'Cleirigh · Massachusetts General Hospital · R01 · FY2017 · MH
Supramolecular nanofiber vaccines
$595,675Joel H Collier · Duke University · R01 · FY2019 · AI
Mycobacterium tuberculosis antigen diversity
$595,619Joel D. Ernst · New York University School Of Medicine · R01 · FY2013 · AI
TB Aftermath
$595,527Jonathan E Golub · Johns Hopkins University · R01 · FY2024 · AI
Host-Pathogen Determinants of M.tb Latency
$595,505Gilla Kaplan · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2011 · AI
UM-IHV AITRP in Nigeria
$595,407William Albert Blattner · University Of Maryland Baltimore · D43 · FY2012 · TW
UM-IHV AITRP in Nigeria
$595,291Manhattan E Charurat · University Of Maryland Baltimore · D43 · FY2014 · TW
NEVADA STATE HEALTH DIVISION'S TUBERCULOSIS PREVENTION, CONTROL AND ELIMINATION
$595,058Susanne Paulson · Nevada State Dept Of Hlth/Human Svcs · U52 · FY2010 · PS
A multi-scale model to predict outcomes of immunomodulation and drug therapy duri
$595,013Denise E Kirschner · University Of Michigan At Ann Arbor · R01 · FY2012 · EB
Longitudinal Analysis of Immune Signatures (IMS) of M. tuberculosis-specific T cells
$594,870Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2023 · AI
BIOCHEMICAL BASIS OF DELAYED TYPE HYPERSENSITIVITY
$594,756Harvard University (Sch Of Public Hlth) · R01 · FY2002 · AI
Longitudinal Study of HIV-Associated Lung Infections in Soweto
$594,747Richard E Chaisson · Johns Hopkins University · R01 · FY2010 · HL
Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa
$594,641David Wesley Dowdy · Johns Hopkins University · R01 · FY2018 · AI